Branded Drugs, Generic Drugs, US, China, Japan, Germany, France, Brazil, Italy, Spain, UK, India, Russia, RoW
The pharma wholesale and distribution market is estimated to grow at a CAGR of 5.6% in the first half of the forecast period. The market is estimated to reach a revenue of $1.3bn in 2023. In 2017, the branded drugs submarket held 79% of the pharma wholesale and distribution market.
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector. In this brand new 277-page report you will receive 93 tables and 107 figures– all unavailable elsewhere. The 277-page report provides clear detailed insight into the pharma wholesale and distribution market. Discover the key drivers and challenges affecting the market. By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope - Global Pharma Wholesale and Distribution Market from 2018-2028
Forecast of the Global Pharma Wholesale and Distribution market by Category: - Generic Drugs - Branded Drugs - Others
This report provides individual revenue forecasts to 2028 for these national markets: - US - Germany - France - Italy - Spain - UK - Japan - China - Brazil - India - Russia - RoW
Each National Market is further segmented into generic drugs, branded drugs and others
Our study discusses the selected leading companies that are the major players in the global pharma and wholesale distribution market: - Alfresa Holdings - AmerisourceBergen - Cardinal Health - McKesson - Medipal - PHOENIX Group - Shanghai Pharma - SINOPHARM - Suzuken - Walgreens Boots Alliance
Our reports have been used by over 10K customers, including:
136 pages •
By Asia Market Information & Development Company
• Dec 2019
This study focuses on China’s Lettuce market trends. In the two past decades, the market has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for...
Global Genitourinary Partnering 2014 to 2019 provides the full collection of Genitourinary disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Genitourinary partnering deals Financial deal terms for headline, upfront and royalty by stage of development Genitourinary...
The Global Regenerative Medicine Partnering 2014-2019: Deal trends, players, financials and forecasts report provides comprehensive understanding and unprecedented access to the regenerative medicine including cell therapy, organ regeneration, stem cells and tissue regeneration partnering deals and agreements entered into by the worlds...
Granulomatosis with Polyangiitis (Wegener Polyangiitis) - Pipeline Review, H2 2019 Summary The latest Pharmaceutical and Healthcare disease pipeline guide Granulomatosis with Polyangiitis (Wegener Polyangiitis) - Pipeline Review, H2 2019, provides an overview of the Granulomatosis with Polyangiitis...
Achondroplasia - Pipeline Review, H2 2019 Summary The latest Pharmaceutical and Healthcare disease pipeline guide Achondroplasia - Pipeline Review, H2 2019, provides an overview of the Achondroplasia (Musculoskeletal Disorders) pipeline landscape. Achondroplasia is a bone growth disorder that...
Ependymoma - Pipeline Review, H2 2019 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Ependymoma - Pipeline Review, H2 2019, provides an overview of the Ependymoma (Oncology) pipeline landscape. Ependymoma is a type of glioma that develops from ependymal cells. Ependymomas...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.